Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study

Gut
A BassiKeith Bodger

Abstract

The potentially high costs of care associated with inflammatory bowel disease (IBD) are recognised but we have little knowledge of the scale, profile, or determinants of these costs in the UK. This study aimed to describe costs of illness for a group of IBD patients and determine factors associated with increased healthcare costs. A university hospital serving a target population of approximately 330 000. A six month cohort of IBD patients receiving any form of secondary care was identified, comprising 307 cases of ulcerative (or indeterminate) colitis and 172 cases of Crohn's disease. Demographic and clinical data were abstracted from clinical records and individual resource use was itemised for all attributable costs (including extraintestinal manifestations). Item costs were derived from national and local sources. Cost data were expressed as mean six month costs per patient (with 95% confidence interval (CI)) obtained using non-parametric bootstrapping. Determinants of cost were analysed using generalised linear regression modelling. A postal survey of patients was undertaken to examine indirect costs, out of pocket expenses, and primary care visits. Inpatient services (medical and/or surgical) were required by 67 patients ...Continue Reading

Associated Clinical Trials

References

Dec 17, 1997·Scandinavian Journal of Gastroenterology·P Blomqvist, A Ekbom
Jan 20, 1999·Alimentary Pharmacology & Therapeutics·F M WardR V Heatley
Jan 23, 1999·European Journal of Gastroenterology & Hepatology·N P ThompsonA J Wakefield
Feb 24, 2000·The American Journal of Gastroenterology·R D CohenL L Mummert
Mar 10, 2000·The American Journal of Gastroenterology·C N BernsteinJ F Blanchard
Aug 19, 2000·The American Journal of Gastroenterology·B G FeaganM V Bala
Sep 28, 2000·European Journal of Gastroenterology & Hepatology·A J NightingaleJ O Hunter
Dec 21, 2000·Alimentary Pharmacology & Therapeutics·G P RubinJ Ling
Oct 5, 2001·Lancet·A RobinsonUNKNOWN Northwest Gastrointestinal Research Group
Apr 19, 2002·Zeitschrift für Gastroenterologie·M RöschH H König
Aug 7, 2002·PharmacoEconomics·Keith Bodger
May 10, 2003·The American Journal of Gastroenterology·Teresa LongobardiCharles N Bernstein
Jun 18, 2003·The American Journal of Gastroenterology·Teresa LongobardiCharles N Bernstein
Nov 19, 2003·European Journal of Gastroenterology & Hepatology·Margaret A StoneRichard Baker

❮ Previous
Next ❯

Citations

Aug 1, 2008·Inflammatory Bowel Diseases·Ashwin N AnanthakrishnanDavid G Binion
Dec 11, 2008·Inflammatory Bowel Diseases·Geoffrey C NguyenThomas A LaVeist
May 2, 2009·Inflammatory Bowel Diseases·Johan MestertonStefan Lindgren
Nov 24, 2011·Inflammatory Bowel Diseases·Charles N BernsteinJames F Blanchard
May 19, 2009·Pediatric Radiology·Sudha A Anupindi, Kassa Darge
Sep 1, 2005·International Journal of Colorectal Disease·Mohammadreza RezailashkajaniMohammad Reza Zali
Jun 4, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Barat J Wolfe, Fuschia M Sirois
Nov 2, 2011·Internal and Emergency Medicine·Antonio Di SabatinoGino R Corazza
Jun 6, 2007·Current Treatment Options in Gastroenterology·Timothy L Zisman, Russell D Cohen
Feb 6, 2010·Nature Reviews. Gastroenterology & Hepatology·Russell D Cohen
Sep 11, 2008·International Journal of Epidemiology·Valérie PittetUNKNOWN Swiss IBD Cohort Study Group
Jun 15, 2007·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Lisa Turnbough, Lindsay Wilson
May 11, 2011·Journal of Clinical Gastroenterology·Arvind J TrindadeThomas A Ullman
May 10, 2008·BMJ : British Medical Journal·J R Fraser CummingsSimon P L Travis
Feb 2, 2008·Digestion·Pierre MichettiChristian Felley
Jun 23, 2011·Therapeutic Advances in Gastroenterology·Marietta Iacucci, Subrata Ghosh
Aug 31, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Gláucio Silva de SouzaJulio Maria Fonseca Chebli
Jan 1, 2009·Clinical and Experimental Gastroenterology·Lauran VogelaarC Janneke van der Woude
Mar 31, 2011·Drug Design, Development and Therapy·Lilliana Oliveira, Russell D Cohen
Jul 1, 2010·Patient Related Outcome Measures·Steven J Bernick, Sunanda Kane
Aug 11, 2006·PharmacoEconomics·Renee StarkReiner Leidl
Jul 6, 2007·PharmacoEconomics·Lizheng ShiHoward Birnbaum
Jan 29, 2011·PharmacoEconomics·Keith Bodger
Nov 27, 2008·World Journal of Gastroenterology : WJG·Selwyn Odes
Sep 15, 2009·World Journal of Gastroenterology : WJG·Peter Laszlo Lakatos
Oct 24, 2013·World Journal of Gastroenterology : WJG·Adam V Weizman, Geoffrey C Nguyen
Feb 13, 2014·Inflammatory Bowel Diseases·Mike van der HaveUNKNOWN Dutch Initiative on Crohn and Colitis
Jan 17, 2014·Nutrition Journal·Barbara C OlendzkiDavid Cave
Apr 1, 2014·Frontline Gastroenterology·Karen Kemp, Mark Sephton
Sep 24, 2011·Journal of Crohn's & Colitis·Alexis PrinceDianne P Reidlinger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.